Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
WITHDRAWN
NCT05104268
EARLY_PHASE1

Study of a New Medical Device for Oral Mucositis

Sponsor: E2Bio Life Sciences, LLC

View on ClinicalTrials.gov

Summary

This is a single-center randomized controlled trial of a new medical device (Bocaliner™) that has been designed to improve the treatment of chemotherapy-induced oral mucositis in patients undergoing cancer treatment. The goal of this study is to determine tolerance and response to the use of Bocaliner™ as reported by patients with chemotherapy and/or radiation therapy-induced oral mucositis.

Official title: A Randomized Study of a New Medical Device for Oral Mucositis (MDOM Trial)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

0

Start Date

2024-11-30

Completion Date

2025-12-31

Last Updated

2026-09-11

Healthy Volunteers

No

Interventions

DEVICE

Bocaliner

Bocaliner is an orally inserted device that is held within the mouth following the administration of mouthwashes, gels, and rinses that are used to treat pain associated with oral mucositis, and to reduce inflammation and to accelerate healing of oral mucositis.

Locations (1)

Hematology Center after Prof. R. Yeolyan MH RA

Yerevan, Armenia